Widespread Prescribing of Stimulants With Other CNS Meds
A large proportion of US adults prescribed Schedule II stimulants are simultaneously receiving other CNS agents, including benzodiazepines, opioids, and antidepressants.
Source: medscape.com
Monument Analytics News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Monument Analytics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Monument Analytics Today - Breaking & Trending Today
Health Care Consulting Leader Monument Analytics Will
Stage Analytics commits to focused growth in Health Economics and Outcomes Research (HEOR), Legal Services, Innovation and Education, and Project...
Source: globenewswire.com
Distribution of Abatement Funds Arising From US Opioid Litigation
This Viewpoint discusses the settlement agreements reached against several major pharmaceutical distributors resulting from the US opioid epidemic and how those
Source: jamanetwork.com
'No need' to suspend immunosuppressive drugs due to COVID-19: No impact on risk outcomes
Back to Healio We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio It is only natural that individuals taking immunosuppressive medications would fear COVID-19. However, recent findings add to a growing body of data indicating that immunosuppression may not elevate risk for worse outcomes for COVID-19 hospitalization. “This is a small amount of good news at a time in this pandemic when we need it,” G. Caleb Alexander, MD, MS , told H ealio Rheumatology. “Doctors and patient...
Source: healio.com